Home › Myelodysplastic Syndromes › Virginia › Arlington
Myelodysplastic Syndromes clinical trials in Arlington, VA
3 studies for Myelodysplastic Syndromes are looking for participants at sites in and around Arlington (within about 30 miles). Open a study to see who can join and how to contact the study team.
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RecruitingPhase 2
- Inova Fairfax Hospital, Falls Church · 4 mi away
- Inova Schar Cancer Institute, Fairfax · 11 mi away
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RecruitingPhase 1/2
- Inova Fairfax Hospital, Falls Church · 4 mi away
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
RecruitingPhase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi away
About Myelodysplastic Syndromes
Myelodysplastic Syndromes (MDS) are rare. They are sometimes found during a routine blood test. Learn symptoms, risk factors, and treatment options.
More about Myelodysplastic Syndromes on MedlinePlus
Myelodysplastic Syndromes trials in other cities
- Houston, TX44 studies
- Baldwin Park, CA26 studies
- Seattle, WA21 studies
- New York City, NY21 studies
- Boston, MA20 studies
- Washington, DC20 studies
- Tampa, FL19 studies
- Miami, FL17 studies
- Chicago, IL14 studies
- Columbus, OH14 studies
- St. Louis, MO14 studies
- Durham, NC14 studies
Other studies in Arlington
- Non-Small Cell Lung Cancer104 studies
- Metastatic Cancer53 studies
- Colorectal Cancer52 studies
- Cancer (all types)48 studies
- Ovarian Cancer46 studies
- Breast Cancer46 studies
- Lung Cancer40 studies
- Endometrial Cancer39 studies
- Pancreatic Cancer34 studies
- Head and Neck Squamous Cell Carcinoma26 studies
- Small Cell Lung Cancer23 studies
- Melanoma20 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.